GlaxoSmithKline (GSK)
40.63
+0.30 +0.74%
NYSE
Apr 24, 16:59
Delayed 2m
USD
View All Key Stats
GSK Key Stats
| Income Statement | |
| Revenue (TTM) | 38.91B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 0.7823 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 1.927B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 66.51% |
| Profit Margin (Quarterly) | -7.15% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 100.74B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 2.573 |
| PE Ratio (TTM) | 51.94 |
| Price to Book Value | -- |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | 2.784B |
| Return on Equity (TTM) | Upgrade |
View All GSK News
GSK News
-
WireHeadlineTime (ET)
-
MT Newswires04/24 15:48
-
SA Breaking News04/24 15:23
-
Business Wire04/24 12:55
-
MT Newswires04/23 07:27
-
Yahoo04/20 11:56
-
Yahoo04/20 08:18
-
MT Newswires04/20 07:43
-
SA Breaking News04/19 13:18
-
Yahoo04/19 09:08
-
MT Newswires04/19 07:33
View All Events
GSK Events
| Date | Type | Description |
|---|---|---|
| 02/07/2019 | Earnings | GlaxoSmithKline PLC Fourth Quarter Earnings Results in 2018 |
| 10/31/2018 | Earnings | GlaxoSmithKline PLC Third Quarter Earnings Results in 2018 |
| 07/25/2018 | Earnings | GlaxoSmithKline PLC Second Quarter Earnings Results in 2018 |
| 05/03/2018 | Misc | GlaxoSmithKline PLC Annual General Meeting in 2017 |
| 04/25/2018 | Earnings | GlaxoSmithKline PLC First Quarter Earnings Results in 2018 |
| 03/13/2018 | Misc | GlaxoSmithKline PLC Annual Report in 2017 |
| 02/22/2018 | Dividends | Amount: 0.6385, Declared Date: Feb 07 2018, Pay Date: Apr 12 2018 |
| 02/07/2018 | Earnings | GlaxoSmithKline PLC Fourth Quarter Earnings Results in 2017 |
| 11/09/2017 | Dividends | Amount: 0.5037, Declared Date: Oct 25 2017, Pay Date: Jan 11 2018 |
| 10/25/2017 | Earnings | GlaxoSmithKline PLC Third Quarter Earnings Results in 2017 |
GSK Fundamentals
Income Statement View Statement
GSK Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
GSK One Page Reports
- One Page Report Download
GSK Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 40.63 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.gsk.com
- Investor Relations URL: http://www.gsk.com/en-gb/investors/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Equity Style: Large Cap/Blend
- Next Earnings Release: Apr. 25, 2018
- Last Earnings Release: Feb. 07, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Feb. 22, 2018
- Description: GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including respiratory and antiviral, vaccines, over-the-counter (OTC) medicines and health-related consumer products.
GSK Excel Add-In Codes
- Name: =YCI("GSK","name")
- Description: =YCI("GSK","description")
- Sector: =YCI("GSK","sector")
- Industry: =YCI("GSK","industry")
- Est. Current Fiscal Year End: =YCI("GSK","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other GSK Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- GSK Tweets Stocktwits
Advertisement
